General Information of the Compound
Compound ID |
CP0189235
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
CHEBI:87690
Show/Hide
|
||||||||||||||||||
Synonyms |
Latixa
(-)-Ranolazine
142387-99-3
95635-55-5
C24H33N3O4
CHEBI:87690
CVT 303
CVT-303
DSSTox_CID_25196
DSSTox_GSID_45196
DSSTox_RID_80743
KEG-1295
Latixa
N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide
NCGC00015897-02
RAN D
RANOLAZINE
RS-43285
RS-43285-003
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazine
Ranolazine (Ranexa)
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine dihydrochloride
Ranolazine extended-release
Ranolazine/Dronedarone Fixed-Dose Combination
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C24H33N3O4
|
||||||||||||||||||
Molecular Weight |
427.545
|
||||||||||||||||||
Canonical SMILES |
COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)
Show/Hide
|
||||||||||||||||||
InChIKey |
XKLMZUWKNUAPSZ-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
142387-99-3
95635-55-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Clinical Information about the Compound